Kancera
KAN | FN
Overview
Corporate Details
- ISIN(s):
- SE0015658570 (+1 more)
- LEI:
- 5493002P3RCOFW6HI207
- Country:
- Sweden
- Address:
- Nanna Svartz väg 4, 171 65 SOLNA
- Website:
- https://kancera.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Develops small-molecule drugs for treating inflammation and cancer. Focused on advancing therapies to clinical trials.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
SenzaGen AB | Sweden | SENZA | |
|
SoftOx Solutions AS | Norway | SOFTX | |
|
Spago Nanomedical AB | Sweden | SPAGO | |
/other/Spermosens_AB_publ-logo.jpg?Expires=1750157501&Signature=IzlZbd24pOKwiWRfyMCDsUfTdW8v3ecSCd9vbKnOIShOC290sKog5y~3M8oNPysZV0QMEjs29Jm2RZO~P5xUECw3dB2tajsgJqwlyGUJ1z--XVIRa9QJyKsDVgUrZmiWSnSBQpq~ihgBgZ~FfdpAUG2kaYooqiHng0Jwhs7FC71XCIhaHLm7DCusAW0Z~ZXN0X7Zpd7Yydi8KpQO1U6-pVO8Y2txlNgGgsssPvP13k4HCk66rs04DywwDzrGO~Y0P-65RIQT4-30-ojhR6x1NxnE5TN~cOSwY4xZ7Xf-YjRmLWcSPf44iCSL1AKaIRSVy9V3gRh-4NbE99pXTAI1Sg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Spermosens AB (publ) | Sweden | SPERM | |
|
Spexis AG | Switzerland | SPEX | |
|
Sprint Bioscience | Sweden | SPRINT | |
|
Stayble Therapeutics AB | Sweden | STABL | |
|
Stem Cells Spin Spolka Akcyjna | Poland | SCS | |
|
Strategic Partners A/S | Denmark | STRAP | |
|
STRIX GROUP PLC | Isle of Man | KETL |